Transmeta Samples 0.09-Micron Efficeon

This site may earn affiliate commissions from the links on this page. Terms of use.

Transmeta Corp. said Thursday that it has begun sampling its Efficeon processor on 90-nm technologies, and plans to enter limited production by mid-year.

The Santa Clara, Calif.-based company continued to lose money, and revenues also decreased from the same period last year.. Transmeta reported a $23.4 million loss on revenue of $5.2 million for the first quarter of its fiscal 2004 year. In the first quarter of fiscal 2003, Transmeta reported a net loss of $20.1 million and $6.0 million in revenue. However, Transmeta’s revenues increased from the fourth quarter of 2003, when the company reported a loss of $21.9 million on revenues of $3.6 million.

“We are making great progress on our 90-nanometer Efficeon processor,” said Matthew Perry, president and chief executive of the company. “In early April, we began sampling these processors and now expect to begin limited production in mid-year, which is earlier than we had previously expected. With our 90-nanometer generation of Efficeon processors, we expect to have a frequency advantage over our competition at the lower power SKUs. We are receiving significant interest in our 90-nanometer Efficeon processors for products intended to ship in the second half of 2004 and in the spring of 2005.”

NEC Electronics licensed the company’s LongRun2 power management technology during the quarter, but the company’s balance sheet did not recognize any revenue from the deal.

Transmeta still holds $113.0 million in reserve cash, down from $120.8 million it held at the end of December.